Inflammation and epithelial to mesenchymal transition in lung transplant recipients: Role in dysregulated epithelial wound repair

American Journal of Transplantation

Volumn 10, Issue 3, 2010, Pages 498-509

  Borthwick, L A ^a   McIlroy, E I ^a   Gorowiec, M R ^a   Brodlie, M ^a   Johnson, G E ^a   Ward, C ^a   Lordan, J L ^a   Corris, P A ^a   Kirby, J A ^a   Fisher, A J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Bronchiolitis obliterans syndrome; Epithelial mesenchymal transition; Interleukin 1; Macrophage; Obilterative bronchiolitis; Transforming growth factor 1; Tumor necrosis factor alpha

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHUS MUCOSA; COCULTURE; CONTROLLED STUDY; EPITHELIUM CELL; GRAFT RECIPIENT; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; LUNG TRANSPLANTATION; MACROPHAGE ACTIVATION; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; WOUND CLOSURE; WOUND HEALING; BIOLOGICAL MODEL; CYTOLOGY; EPITHELIUM; FIBROSIS; MACROPHAGE; MESODERM; METABOLISM; PATHOLOGY; PROCEDURES; TUMOR CELL LINE;

CELL LINE, TUMOR; COCULTURE TECHNIQUES; EPITHELIUM; FIBROSIS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-8; LUNG TRANSPLANTATION; MACROPHAGES; MESODERM; MODELS, BIOLOGICAL; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 76949108858     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02953.x     Document Type: Article

References (49)

1. Christie JD, Edwards LB, Aurora P et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth official adult lung and heart/lung transplantation report-2008. J Heart Lung Transplant 2008 27 : 957 969.
2. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002 166 : 440 444.
3. Estenne M, Maurer JR, Boehler A et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002 21 : 297 310.
4. Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 2003 22 : 1007 1018.
5. Yousem SA, Berry GJ, Cagle PT et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996 15 (1 Pt 1 1 15.
6. Borthwick LA, Parker SM, Brougham KA et al. Epithelial to Mesenchymal Transition (EMT) and airway remodelling after human lung transplantation. Thorax 2009 64 : 770 777.
7. Hodge S, Holmes M, Banerjee B et al. Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition. Am J Transplant 2009 9 : 727 733.
8. Wu Z, Yang L, Cai L et al. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir Res 2007 8 : 1 11.
9. Ward C, Forrest IA, Murphy DM et al. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 2005 60 : 865 871.
10. Jain R, Shaul PW, Borok Z, Willis BC. Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1. Am J Respir Cell Mol Biol 2007 37 : 38 47.
11. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003 112 : 1776 1184.
12. Bergmann M, Tiroke A, Schafer H, Barth J, Haverich A. Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation. Scand Cardiovasc J 1998 32 : 97 103.
13. El-Gamel A, Sim E, Hasleton P et al. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 1999 18 : 828 837.
14. Elssner A, Jaumann F, Dobmann S et al. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: Proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group. Transplantation 2000 70 : 362 367.
15. Zheng L, Walters EH, Wang N et al. Effect of inhaled fluticasone propionate on BAL TGF-beta(1) and bFGF concentrations in clinically stable lung transplant recipients. J Heart Lung Transplant 2004 23 : 446 455.
16. Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respiratory research. 2005 6 : 56 70.
17. Willis BC, Borok Z. TGF-beta-induced EMT: Mechanisms and implications for fibrotic lung disease. Am J Physiol 2007 293 : L525 L534.
18. Willis BC, Liebler JM, Luby-Phelps K et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: Potential role in idiopathic pulmonary fibrosis. Am J Pathol 2005 166 : 1321 1332.
19. Zhang M, Zhang Z, Pan HY, Wang DX, Deng ZT, Ye XL. TGF-beta1 induces human bronchial epithelial cell-to-mesenchymal transition in vitro. Lung 2009 187 : 187 194.
20. Vanaudenaerde BM, De Vleeschauwer SI, Vos R et al. The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2008 8 : 1911 1920.
21. Riise GC, Williams A, Kjellstrom C, Schersten H, Andersson BA, Kelly FJ. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung. Eur Respir J 1998 12 : 82 88.
22. Oyaizu T, Okada Y, Shoji W et al. Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation. Transplantation 2003 76 : 1214 1220.
23. Forrest IA, Murphy DM, Ward C et al. Primary airway epithelial cell culture from lung transplant recipients. Eur Respir J 2005 26 : 1080 1085.
24. DiGiovine B, Lynch JP 3rd., Martinez FJ et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: Role of IL-8. J Immunol 1996 157 : 4194 4202.
25. Anderson RL, Hiemstra PS, Ward C et al. Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Eur Respir J 2008 32 : 670 677.
26. Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006 174 : 566 570.
27. Yates B, Murphy DM, Forrest IA et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005 172 : 772 775.
28. Ball AP. Azithromycin: An interim analysis. J Int Med Res. 1991 19 : 446 450.
29. Meyer M, Huaux F, Gavilanes X et al. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. Am J Respir Cell Mol Biol 2009 41 : 590 602.
30. Gieling RG, Wallace K, Han YP. Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol 2009 296 : G1324 G1331.
31. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001 107 : 1529 1536.
32. Liu W, Ding I, Chen K et al. Interleukin 1beta (IL1B) signaling is a critical component of radiation-induced skin fibrosis. Radiation research 2006 165 : 181 191.
33. Margetts PJ, Kolb M, Yu L et al. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol 2002 160 : 2285 2294.
34. Vesey DA, Cheung CW, Cuttle L, Endre ZA, Gobe G, Johnson DW. Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney Int 2002 62 : 31 40.
35. Jones LK, O'Sullivan KM, Semple T et al. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol Dial Transplant 2009 24 : 3024 3032.
36. Thomay AA, Daley JM, Sabo E et al. Disruption of interleukin-1 signaling improves the quality of wound healing. Am J Pathol 2009 174 : 2129 2136.
37. Havemose-Poulsen A, Holmstrup P. Factors affecting IL-1-mediated collagen metabolism by fibroblasts and the pathogenesis of periodontal disease: A review of the literature. Crit Rev Oral Biol Med 1997 8 : 217 236.
38. Vandenabeele P, Declercq W, Beyaert R, Fiers W. Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol 1995 5 : 392 399.
39. Farkas L, Hahn MC, Schmoczer M et al. Expression of CXC chemokine receptors 1 and 2 in human bronchial epithelial cells. Chest 2005 128 : 3724 3734.
40. O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: Signal transduction during inflammation and host defense. Sci STKE 2000 1 11.
41. Yamaguchi K, Shirakabe K, Shibuya H et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 1995 270 : 2008 2011.
42. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999 398 : 252 256.
43. O'Neill LA. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr Top Microbiol Immunol 2002 270 : 47 61.
44. Blonska M, Shambharkar PB, Kobayashi M et al. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation. J Biol Chem 2005 280 : 43056 43063.
45. Ono K, Ohtomo T, Ninomiya-Tsuji J, Tsuchiya M. A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-beta. Biochem Biophys Res Commun 2003 307 : 332 337.
46. Kim JH, Jang YS, Eom KS et al. Transforming growth factor beta1 induces epithelial-to-mesenchymal transition of A549 cells. J Korean Med Sci 2007 22 : 898 904.
47. Neurohr C, Nishimura SL, Sheppard D. Activation of transforming growth factor-beta by the integrin alpha v beta 8 delays epithelial wound closure. Am J Respir Cell Mol Biol 2006 35 : 252 259.
48. Nishida K, Ohashi Y, Nezu E, Yamamoto S, Kinoshita S, Fujita K. [Transforming growth factor-beta (TGF-beta) inhibits epithelial wound healing of organ-cultured rabbit cornea]. Nippon Ganka Gakkai zasshi 1993 97 : 899 905.
49. Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990 141 : 765 788.